GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » EV-to-Revenue

Star Lake Bioscience Co (SHSE:600866) EV-to-Revenue : 0.73 (As of Jun. 30, 2025)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co EV-to-Revenue?

EV-to-Revenue is calculated as enterprise value divided by its revenue. As of today, Star Lake Bioscience Co's enterprise value is ¥12,616 Mil. Star Lake Bioscience Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 was ¥17,174 Mil. Therefore, Star Lake Bioscience Co's EV-to-Revenue for today is 0.73.

The historical rank and industry rank for Star Lake Bioscience Co's EV-to-Revenue or its related term are showing as below:

SHSE:600866' s EV-to-Revenue Range Over the Past 10 Years
Min: 0.43   Med: 3.14   Max: 8.04
Current: 0.73

During the past 13 years, the highest EV-to-Revenue of Star Lake Bioscience Co was 8.04. The lowest was 0.43. And the median was 3.14.

SHSE:600866's EV-to-Revenue is ranked better than
87.68% of 990 companies
in the Biotechnology industry
Industry Median: 7.755 vs SHSE:600866: 0.73

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

As of today (2025-06-30), Star Lake Bioscience Co's stock price is ¥6.91. Star Lake Bioscience Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 was ¥10.34. Therefore, Star Lake Bioscience Co's PS Ratio for today is 0.67.


Star Lake Bioscience Co EV-to-Revenue Historical Data

The historical data trend for Star Lake Bioscience Co's EV-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co EV-to-Revenue Chart

Star Lake Bioscience Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
EV-to-Revenue
Get a 7-Day Free Trial Premium Member Only Premium Member Only 3.45 2.67 0.74 0.61 0.72

Star Lake Bioscience Co Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
EV-to-Revenue Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.60 0.72 0.71 0.72 0.68

Competitive Comparison of Star Lake Bioscience Co's EV-to-Revenue

For the Biotechnology subindustry, Star Lake Bioscience Co's EV-to-Revenue, along with its competitors' market caps and EV-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's EV-to-Revenue Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's EV-to-Revenue distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's EV-to-Revenue falls into.


;
;

Star Lake Bioscience Co EV-to-Revenue Calculation

EV-to-Revenue is a similar ratio to PS Ratio, except here Enterprise Value instead of Market Cap is used in the calculation.

Star Lake Bioscience Co's EV-to-Revenue for today is calculated as:

EV-to-Revenue=Enterprise Value (Today)/Revenue (TTM)
=12615.711/17174.181
=0.73

Star Lake Bioscience Co's current Enterprise Value is ¥12,616 Mil.
Star Lake Bioscience Co's Revenue for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥17,174 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Star Lake Bioscience Co  (SHSE:600866) EV-to-Revenue Explanation

The reason Enterprise Value is used is because Enterprise Value is more real in reflecting how much an investor pays when buying a company. For detais, go to Enterprise Value.

Star Lake Bioscience Co's PS Ratiofor today is calculated as:

PS Ratio=Share Price (Today)/Revenue per Share (TTM)
=6.91/10.336
=0.67

Star Lake Bioscience Co's share price for today is ¥6.91.
Star Lake Bioscience Co's Revenue per Share for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥10.34.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Star Lake Bioscience Co EV-to-Revenue Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's EV-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Executives
Chen Wu Director
Liu Xian Yi Director
Liao Jie Ming senior management
Chen Chao Ju Director
Li Qing Lin Supervisors
Zhong Zi Rong Director

Star Lake Bioscience Co Headlines

No Headlines